Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A

Adams, 1977, Pathology of multiple sclerosis: progression of the lesion, Br. med. Bull., 33, 15, 10.1093/oxfordjournals.bmb.a071388 Barkhof, 1991, Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis, Neurology, 41, 1219, 10.1212/WNL.41.8.1219 Barlow, 1956, A study ofabnormal blood-brain barrier permeability in experimental allergic encephalomyelitis, J. Neuropath. exp. Neurol., 15, 196, 10.1097/00005072-195604000-00005 Bastianello, 1990, Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis, Neurology, 40, 591, 10.1212/WNL.40.4.591 Begley, 1990, Permeability of the blood-brain barrier to the imunosuppressive cyclic peptide cyclosporin A, J. Neurochem., 55, 1222, 10.1111/j.1471-4159.1990.tb03128.x Bolton, 1982, The effect of cyclosporin A on adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat, Clin. exp. Immun., 47, 127 Bolton, 1982, Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis, J. Neural. Sci., 56, 147, 10.1016/0022-510X(82)90138-1 Bolton, 1989, The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat, Life Sci., 45, 97, 10.1016/0024-3205(89)90441-4 Bolton, 1984, Prostaglandin and thromboxane levels in central nervous system tissues from rats during the induction and development of experimental allergic encephalomyelitis (EAE), Immunopharmacology, 7, 101, 10.1016/0162-3109(84)90059-6 Bolton, 1994, Aspects of the biochemical pharmacology of neurovascular disruption in experimental allergic encephalomyelitis (EAE), J. Neuroimmun., 52, 113, 10.1016/0165-5728(94)90096-5 Bolton, 1986, A study of the prostaglandin and thromboxane content of the central nervous tissues with the development of chronic relapsing allergic encephalomyelitis, J. Neuroimmun., 10, 201, 10.1016/0165-5728(86)90102-5 Bradbury, 1985, The blood-brain barrier: transport across the cerebral endothelium, Circulation Res., 57, 213, 10.1161/01.RES.57.2.213 Burnham, 1991, The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions, Neurology, 41, 1349, 10.1212/WNL.41.9.1349 Claudio, 1989, Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis, Am. J. Path., 135, 1157 Daniel, 1981, Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis, J. Neurol. Sci., 52, 211, 10.1016/0022-510X(81)90006-X Desai, 1989, Pharmacological comparison of active and passive experimental allergic encephalomyelitis in the rat, Agents. Actions, 27, 351, 10.1007/BF01972820 Dupont, 1988, Immunological actions of corticosteroids and cyclosporin A, Curr. Opin. Immun., 1, 253, 10.1016/0952-7915(88)90010-6 Goldstein, 1986, The blood-brain barrier, Scient. Am., 255, 70, 10.1038/scientificamerican0986-74 Grossman, 1988, Multiple sclerosis: serial study of gadolinium-enhanced MR imaging, Radiology, 169, 117, 10.1148/radiology.169.1.3420246 Hedley-Whyte, 1986, Effect of dexamethasone on blood-brain barrier in the normal mouse, Ann. Neurol., 19, 373, 10.1002/ana.410190411 Hinrichs, 1983, The influence of cyclosporin A on the development of actively induced and passively transferred experimental allergic encephalomyelitis, Cell. Immun., 77, 202, 10.1016/0008-8749(83)90020-5 Juhler, 1984, Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat, Brain Res., 302, 347, 10.1016/0006-8993(84)90249-X Kesselring, 1989, Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone, J. Neural. Neurosurg. Psychiat., 52, 14, 10.1136/jnnp.52.1.14 Klaus, 1986, Does cyclosporin act in vivo as it does in vitro?, Immun. Today, 7, 101, 10.1016/0167-5699(86)90148-9 Koenig, 1989, Blood-brain barrier breakdown in cold-injured brain is linked to a biphasic stimulation of ornithine decarboxylase activity and polyamine synthesis: both are coordinately inhibited by verapamil, dexamethasone, and aspirin, J. Neurochem., 52, 101, 10.1111/j.1471-4159.1989.tb10903.x Koenig, 1992, Capillary NMDA receptors regulate blood-brain barrier function and breakdown, Brain Res., 588, 297, 10.1016/0006-8993(92)91589-7 Komarek, 1971, Chemical prevention of experimental allergic encephalomyelitis in rats: a quantitative evaluation of steroids and various non-steroid drugs, Archs int. Pharmacodyn., 193, 249 Leibowitz, 1969, Cerebral vascular permeability in experimental allergic encephalomyelitis, Neuropath. Pol., 7, 303 Leibowitz, 1972, Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis, Immunology, 22, 859 Levine, 1980, Therapy of allergic encephalomyelitis in rats after onset of paralysis, 199 Lew, 1988, Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone, J. Immun., 140, 1895, 10.4049/jimmunol.140.6.1895 Long, 1985, Blood-brain barrier: endogenous modulation by adrenal-cortical function, Science, 227, 1580, 10.1126/science.3975627 Ludowyk, 1993, Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged rats, J. Neuroimmun., 48, 121, 10.1016/0165-5728(93)90184-Z MacMicking, 1992, Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T-cells, J. exp. Med., 176, 303, 10.1084/jem.176.1.303 McConahey, 1980, Radioiodination of proteins by the use of the Chloamine-T method, Vol. 70, 210 Milanese, 1989, Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts, Eur. Neurol., 29, 10, 10.1159/000116368 Moncada, 1992, The 1991 Ulf von Euler lecture, 145, 201 Moncada, 1993, The l-arginine-nitric oxide pathway, N. Engl. J. Med., 329, 2002, 10.1056/NEJM199312303292706 Mühl, 1993, Cyclosporin derivatives inhibit interleukin-I β induction of nitric oxide synthase in renal mesangial cells, Eur. J. Pharmac., 249, 95, 10.1016/0014-2999(93)90666-6 Nooter, 1984, Blood and tissue distribution of cyclosporin A after a single oral dose in the rat, Experientia, 40, 559, 10.1007/BF01982329 Osman, 1987, A simple in vitro method of radiolabelling human erythrocytes in whole blood with 113αIntropolanate, Eur. J. Haematol., 39, 125, 10.1111/j.1600-0609.1987.tb00741.x Palmer, 1992, The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids, Br. J. Pharmac., 105, 11, 10.1111/j.1476-5381.1992.tb14202.x Pardridge, 1979, Transport of steroid hormones through the rat blood-brain barrier: primary role of albumin-bound hormone, J. clin. Invest., 64, 145, 10.1172/JCI109433 Paterson, 1978, The demyelinating diseases: clinical and experimental studies in animals and man, 1400 Risau, 1990, Development of the blood-brain barrier, Trends Neurosci., 13, 174, 10.1016/0166-2236(90)90043-A Rudge, 1989, Randomised double-blind controlled trial of cyclosporin in multiple sclerosis, J. Neurol. Neurosurg. Psychiat., 52, 559, 10.1136/jnnp.52.5.559 Rumjanek, 1984, Mononuclear cell accumulation and plasma protein extravasation (PPE) during induction, remission and re-challenge of experimental allergic encephalomyelitis in the rat, J. Neurol. Sci., 65, 81, 10.1016/0022-510X(84)90069-8 Ruutiainen, 1991, Treatment of acute exacerbations in early multiple sclerosis: cyclosporin A or prednisolone?, Acta Neurol. scand., 83, 52, 10.1111/j.1600-0404.1991.tb03958.x Ryffel, 1993, Cyclosporin binding proteins: identification, distribution, function and relation to FK binding proteins, Biochem. Pharmac., 46, 1, 10.1016/0006-2952(93)90341-S 1990, Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomised, double-blinded, placebo-controlled clinical trial, Ann. Neurol., 27, 591, 10.1002/ana.410270603 Traugott, 1989, Detailed analysis of early immunopathologic events during lesion formation in acute experimental autoimmune encephalomyelitis, Cell. Immun., 119, 114, 10.1016/0008-8749(89)90228-1 Troiano, 1987, Steroid therapy in multiple sclerosis, Archs Neurol., 44, 803, 10.1001/archneur.1987.00520200007008 Trout, 1986, Blood-brain barrier breakdown by cold injury: polyamine signals mediate acute stimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries, Lab. Invest., 55, 622 Waage, 1988, Glucocorticoids suppress the production oftumour necrosis factor by lipopolysaccharide-stimulated human monocytes, Immunology, 63, 299